Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5177)
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
984
Price
$1.32
Total Value
$1.30K
Shares Held After
955,493
% of Holdings
0.1%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,452
Price
$25.00
Total Value
$36.30K
Shares Held After
117,227
% of Holdings
1.2%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
200
Price
$77.71
Total Value
$15.54K
Shares Held After
31,771
% of Holdings
0.6%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
700
Price
$76.67
Total Value
$53.67K
Shares Held After
31,971
% of Holdings
2.1%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,400
Price
$75.48
Total Value
$105.68K
Shares Held After
32,671
% of Holdings
4.1%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,847
Price
$74.69
Total Value
$137.96K
Shares Held After
34,071
% of Holdings
5.1%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,853
Price
$73.89
Total Value
$210.81K
Shares Held After
35,918
% of Holdings
7.4%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
4,286
Price
$0.72
Total Value
$3.09K
Shares Held After
10,523,617
% of Holdings
0.0%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
4,000
Price
$0.70
Total Value
$2.80K
Shares Held After
10,519,331
% of Holdings
0.0%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
11,233
Price
$1.93
Total Value
$21.73K
Shares Held After
2,884,522
% of Holdings
0.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,100
Price
$25.82
Total Value
$131.68K
Shares Held After
377,802
% of Holdings
1.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,781
Price
$25.57
Total Value
$173.39K
Shares Held After
382,902
% of Holdings
1.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
2,667
Price
$98.00
Total Value
$261.37K
Shares Held After
149,168
% of Holdings
1.8%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
100
Price
$99.00
Total Value
$9.90K
Shares Held After
0
% of Holdings
100.0%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
3,083
Price
$98.32
Total Value
$303.12K
Shares Held After
100
% of Holdings
96.9%
Doximity, Inc. (DOCS)
Sitaram Siddharth — Chief Accounting Officer
Shares
2,613
Price
$30.68
Total Value
$80.17K
Shares Held After
101,432
% of Holdings
2.5%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
382
Price
$60.14
Total Value
$22.97K
Shares Held After
1,291,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
2,118
Price
$59.52
Total Value
$126.06K
Shares Held After
1,291,976
% of Holdings
0.2%
CRISPR Therapeutics AG (CRSP)
George Simeon — Director
Shares
14,514
Price
$49.63
Total Value
$720.37K
Shares Held After
15,486
% of Holdings
48.4%
Progyny, Inc. (PGNY)
Cummings Melissa B — Chief Operating Officer
Shares
1,879
Price
$28.00
Total Value
$52.61K
Shares Held After
66,496
% of Holdings
2.7%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
450
Price
$214.15
Total Value
$96.37K
Shares Held After
1,599,258
% of Holdings
0.0%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
38,774
Price
$213.47
Total Value
$8.28M
Shares Held After
1,599,708
% of Holdings
2.4%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
775
Price
$17.35
Total Value
$13.45K
Shares Held After
55,334
% of Holdings
1.4%
VEEVA SYSTEMS INC (VEEV)
Faddis Jonathan — SVP, Gen. Counsel, Secretary
Shares
708
Price
$298.19
Total Value
$211.12K
Shares Held After
4,130
% of Holdings
14.6%
VEEVA SYSTEMS INC (VEEV)
Faddis Jonathan — SVP, Gen. Counsel, Secretary
Shares
975
Price
$299.29
Total Value
$291.81K
Shares Held After
4,838
% of Holdings
16.8%
VEEVA SYSTEMS INC (VEEV)
Faddis Jonathan — SVP, Gen. Counsel, Secretary
Shares
3,515
Price
$300.14
Total Value
$1.05M
Shares Held After
5,813
% of Holdings
37.7%
Nurix Therapeutics, Inc. (NRIX)
GREGORY JULIA P — Director
Shares
22,583
Price
$23.40
Total Value
$528.53K
Shares Held After
10,750
% of Holdings
67.7%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
170,000
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,451
Price
$85.00
Total Value
$208.33K
Shares Held After
169,900
% of Holdings
1.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,449
Price
$84.07
Total Value
$205.89K
Shares Held After
167,449
% of Holdings
1.5%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
745,588
% of Holdings
0.0%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$85.00
Total Value
$209.95K
Shares Held After
745,488
% of Holdings
0.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$84.07
Total Value
$207.65K
Shares Held After
743,018
% of Holdings
0.3%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
505
Price
$126.55
Total Value
$63.91K
Shares Held After
132,616
% of Holdings
0.4%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
597
Price
$125.33
Total Value
$74.82K
Shares Held After
133,121
% of Holdings
0.4%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
920
Price
$124.37
Total Value
$114.42K
Shares Held After
133,718
% of Holdings
0.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
2,604
Price
$123.29
Total Value
$321.05K
Shares Held After
134,638
% of Holdings
1.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
2,072
Price
$122.62
Total Value
$254.06K
Shares Held After
137,242
% of Holdings
1.5%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
476
Price
$121.14
Total Value
$57.66K
Shares Held After
139,314
% of Holdings
0.3%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
50
Price
$781.47
Total Value
$39.07K
Shares Held After
47,833
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
463
Price
$780.63
Total Value
$361.43K
Shares Held After
47,883
% of Holdings
1.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
380
Price
$779.59
Total Value
$296.24K
Shares Held After
48,346
% of Holdings
0.8%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
454
Price
$778.64
Total Value
$353.50K
Shares Held After
48,726
% of Holdings
0.9%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
38
Price
$777.76
Total Value
$29.55K
Shares Held After
49,180
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
66
Price
$776.31
Total Value
$51.24K
Shares Held After
49,218
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
376
Price
$775.46
Total Value
$291.57K
Shares Held After
49,284
% of Holdings
0.8%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
121
Price
$774.48
Total Value
$93.71K
Shares Held After
49,660
% of Holdings
0.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
224
Price
$773.40
Total Value
$173.24K
Shares Held After
49,781
% of Holdings
0.4%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
211
Price
$772.56
Total Value
$163.01K
Shares Held After
50,005
% of Holdings
0.4%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
283
Price
$771.56
Total Value
$218.35K
Shares Held After
50,216
% of Holdings
0.6%
5177 transactions